USA Health urges families to take measures to avoid RSV and other respiratory illnesses

GCM Staff Report
Posted 10/19/24

A notable increase in severe cases of respiratory syncytial virus (RSV) has led to a surge in pediatric hospitalizations at USA Health Children's & Women's Hospital according to a news release.

This item is available in full to subscribers.

Subscribe to continue reading. Already a subscriber? Sign in

Get the gift of local news. All subscriptions 50% off for a limited time!

You can cancel anytime.
 

Please log in to continue

Log in

USA Health urges families to take measures to avoid RSV and other respiratory illnesses

Posted

A notable increase in severe cases of respiratory syncytial virus (RSV) has led to a surge in pediatric hospitalizations at USA Health Children's & Women's Hospital according to a news release.

Health officials are sounding the alarm as dozens of children receive treatment for the virus, which can pose significant risks, particularly to young infants and older adults.

RSV is a common respiratory illness that usually results in mild, cold-like symptoms. However, it can be particularly dangerous for babies, toddlers and those with preexisting health conditions.

Dr. Benjamin Estrada, a professor of pediatrics and head of the infectious diseases division at the University of South Alabama, urges parents and caregivers to prioritize immunization for their infants.

"We are urging parents and caregivers to make sure their infants are immunized against RSV," Estrada said in the release.

Vaccination is not just for the youngest. Older adults are also encouraged to receive the RSV vaccine, which is approved for those aged 75 and older, as well as for individuals aged 60-74 who are at a high risk of severe RSV complications.

Besides making sure young children are immunized and older adults are vaccinated, everyone needs to be diligent about ensuring children wash their hands, cover their coughs, and stay away from other sick children as much as possible, Estrada said. Parents are advised to monitor their children for symptoms, which often mimic a severe cold and can last up to two weeks.

According to the Centers for Disease Control and Prevention (CDC), RSV can lead to more serious health complications, such as bronchiolitis and pneumonia, especially in high-risk populations. These groups include young infants and children with underlying health issues, such as asthma or immune disorders.

To combat the rising RSV cases, health officials recommend several prevention strategies for expectant mothers, infants, and young children:

Infants under 8 months: One dose of the RSV antibody (nirsevimab) within one week of birth for those born during or entering their first RSV season.

Infants and children aged 8-19 months: One dose of nirsevimab for those at increased risk of severe RSV disease, administered shortly before their second RSV season.

Children aged 24 months and younger with certain health conditions: Monthly doses of Palivizumab during the RSV season.

Expectant mothers: Receive the RSV vaccine during prenatal care.

To limit the spread of RSV, everyone is encouraged to practice good hygiene and health habits, including staying home when sick, covering coughs and sneezes, washing hands frequently with soap and water for at least 20 seconds and avoiding close contact with others.